261 related articles for article (PubMed ID: 9412547)
1. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
[TBL] [Abstract][Full Text] [Related]
2. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
Schelfhout V; Van De Velde V; Pauwels R; Joos G
Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
[TBL] [Abstract][Full Text] [Related]
3. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
Smith LJ; Hanby LA; Lavins BJ; Simonson SG
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
[TBL] [Abstract][Full Text] [Related]
4. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
Pearlman DS; Ostrom NK; Bronsky EA; Bonuccelli CM; Hanby LA
J Pediatr; 1999 Mar; 134(3):273-9. PubMed ID: 10064661
[TBL] [Abstract][Full Text] [Related]
5. Summary of clinical trials with zafirlukast.
Calhoun WJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction.
Richter K; Jörres RA; Magnussen H
Eur Respir J; 2000 Apr; 15(4):693-9. PubMed ID: 10780761
[TBL] [Abstract][Full Text] [Related]
8. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
9. Exercise increases sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
Sheppard D; Saisho A; Nadel JA; Boushey HA
Am Rev Respir Dis; 1981 May; 123(5):486-91. PubMed ID: 7235370
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide.
Balmes JR; Fine JM; Sheppard D
Am Rev Respir Dis; 1987 Nov; 136(5):1117-21. PubMed ID: 3674573
[TBL] [Abstract][Full Text] [Related]
12. Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Cazzola M; Boveri B; Carlucci P; Santus P; DiMarco F; Centanni S; Allegra L
Pulm Pharmacol Ther; 2000; 13(6):301-5. PubMed ID: 11061985
[TBL] [Abstract][Full Text] [Related]
13. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness.
Dessanges JF; Préfaut C; Taytard A; Matran R; Naya I; Compagnon A; Dinh-Xuan AT
J Allergy Clin Immunol; 1999 Dec; 104(6):1155-61. PubMed ID: 10588995
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
[TBL] [Abstract][Full Text] [Related]
15. Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma.
Carratù P; Morelli N; Freire AX; Pugazhenthi M; Guerra S; Umberger R; Allegra L
Respiration; 2003; 70(3):249-53. PubMed ID: 12915743
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.
Pearlman DS; Lampl KL; Dowling PJ; Miller CJ; Bonuccelli CM
Clin Ther; 2000 Jun; 22(6):732-47. PubMed ID: 10929920
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sulfur dioxide-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects.
Sheppard D; Nadel JA; Boushey HA
Am Rev Respir Dis; 1981 Sep; 124(3):257-9. PubMed ID: 6792956
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
Smith LJ; Glass M; Minkwitz MC
Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
[TBL] [Abstract][Full Text] [Related]
19. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
[TBL] [Abstract][Full Text] [Related]
20. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
Murata Y; Sugimoto O
Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
